Skip to main content
. Author manuscript; available in PMC: 2014 Feb 1.
Published in final edited form as: Drug Alcohol Depend. 2012 Aug 22;128(1-2):64–70. doi: 10.1016/j.drugalcdep.2012.08.001

Figure 2.

Figure 2

Mean subjective drug effect ratings (Panel A) and heart rate assessments (Panel B) obtained during the cannabis challenge session conducted on the 5th day of each dronabinol maintenance phase. In order to account for pre-cannabis exposure (baseline) effects of oral dronabinol on these measures, data are presented as a change from baseline to better illustrate the relative effects of smoked cannabis.